Patents by Inventor Ian C. Scott

Ian C. Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL33 ANTIBODIES AND METHODS OF USING THE SAME
    Publication number: 20240016929
    Abstract: The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders.
    Type: Application
    Filed: July 5, 2023
    Publication date: January 18, 2024
    Inventors: Emma S. COHEN, David C. LOWE, Robin BUTLER, Ian C. SCOTT, Katherine A. VOUSDEN, Martin D. STRAIN, Sara CARMEN, Elizabeth H. ENGLAND, Benjamin P. KEMP, David G. REES, Catherine L. OVERED-SAYER, Tomas M. MUSTELIN, Matthew SLEEMAN, Kirsty HOUSLAY
  • Polynucleotides encoding IL33 antibodies and methods of using the same
    Patent number: 11738081
    Abstract: The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: August 29, 2023
    Assignee: MEDIMMUNE LIMITED
    Inventors: Emma S. Cohen, David C. Lowe, Robin Butler, Ian C. Scott, Katherine A. Vousden, Martin D. Strain, Sara Carmen, Elizabeth H. England, Benjamin P. Kemp, David G. Rees, Catherine L. Overed-Sayer, Tomas M. Mustelin, Matthew Sleeman, Kirsty Houslay
  • NOVEL IL33 FORM, MUTATED FORMS OF IL33, ANTIBODIES, ASSAYS AND METHODS OF USING THE SAME
    Publication number: 20200353078
    Abstract: The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders.
    Type: Application
    Filed: April 10, 2020
    Publication date: November 12, 2020
    Inventors: Emma S. Cohen, David C. Lowe, Robin Butler, Ian C. Scott, Katherine A. Vousden, Martin D. Strain, Sara Carmen, Elizabeth H. England, Benjamin P. Kemp, David G. Rees, Catherine L. Overed-Sayer, Tomas M. Mustelin, Matthew Sleeman, Kirsty Houslay
  • IL33 form, mutated forms of IL33, antibodies, assays and methods of using the same
    Patent number: 10668150
    Abstract: The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: June 2, 2020
    Assignee: MEDIMMUNE LIMITED
    Inventors: Emma S. Cohen, David C. Lowe, Robin Butler, Ian C. Scott, Katherine A. Vousden, Martin D. Strain, Sara Carmen, Elizabeth H. England, Benjamin P. Kemp, David G. Rees, Catherine L. Overed-Sayer, Tomas M. Mustelin, Matthew Sleeman, Kirsty Houslay
  • A NOVEL IL33 FORM, MUTATED FORMS OF IL33, ANTIBODIES, ASSAYS AND METHODS OF USING THE SAME
    Publication number: 20180207265
    Abstract: The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders.
    Type: Application
    Filed: March 30, 2016
    Publication date: July 26, 2018
    Inventors: Emma S. Cohen, David C. Lowe, Robin Butler, Ian C. Scott, Katherine A. Vousden, Martin D. Strain, Sara Carmen, Elizabeth H. England, Benjamin P. Kemp, David G. Rees, Catherine L. Overed-Sayer, Tomas M. Mustelin, Matthew Sleeman, Kirsty Houslay
  • Media gateway health
    Patent number: 8717883
    Abstract: Data is received from a media gateway relating to a congestion level in the media gateway. In a computer having a processor and a memory, at least a first datum and a second datum included in the data are evaluated. Based on the evaluation, it is determined whether the congestion level exceeds a predetermined level. The congestion level is reported, including whether the congestion level exceeds the predetermined level.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: May 6, 2014
    Assignee: Verizon Patent and Licensing Inc.
    Inventors: James N. Russell, Ian C. Scott, Bob E. Taylor, Roy Curtis Shell, IV, Kenny M. Hawkins
  • Method and system for providing signaling gateway management
    Patent number: 8331348
    Abstract: An approach is provided for signaling gateway management. Data from a plurality of signaling gateways corresponding to a plurality of trunks of a telecommunications network is automatically retrieved, each signaling gateway being configured to convert circuit-switched signaling to packet-switched signaling. The data is stored. An operating state for each of the plurality of trunks is determined based on the data to perform trending analysis for the operation of one or more of the plurality of trunks.
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: December 11, 2012
    Assignee: Verizon Patent and Licensing Inc.
    Inventors: James N. Russell, Roy C. Shell, Ian C. Scott, Kenny M. Hawkins, Bob E. Taylor
  • MEDIA GATEWAY HEALTH
    Publication number: 20120155297
    Abstract: Data is received from a media gateway relating to a congestion level in the media gateway. In a computer having a processor and a memory, at least a first datum and a second datum included in the data are evaluated. Based on the evaluation, it is determined whether the congestion level exceeds a predetermined level. The congestion level is reported, including whether the congestion level exceeds the predetermined level.
    Type: Application
    Filed: December 17, 2010
    Publication date: June 21, 2012
    Applicant: Verizon Patent and Licensing Inc.
    Inventors: James N. Russell, Ian C. Scott, Bob E. Taylor, Roy Curtis Shell, IV, Kenny M. Hawkins
  • METHOD AND SYSTEM FOR PROVIDING SIGNALING GATEWAY MANAGEMENT
    Publication number: 20110103371
    Abstract: An approach is provided for signaling gateway management. Data from a plurality of signaling gateways corresponding to a plurality of trunks of a telecommunications network is automatically retrieved, each signaling gateway being configured to convert circuit-switched signaling to packet-switched signaling. The data is stored. An operating state for each of the plurality of trunks is determined based on the data to perform trending analysis for the operation of one or more of the plurality of trunks.
    Type: Application
    Filed: November 2, 2009
    Publication date: May 5, 2011
    Applicant: VERIZON PATENT AND LICENSING INC.
    Inventors: James N. Russell, Roy C. Shell, Ian C. Scott, Kenny M. Hawkins, Bob E. Taylor
  • Mammalian tolloid-like gene and protein
    Patent number: 6579702
    Abstract: A mammalian gene encoding a tolloid-like protein distinct from human or murine BMP-1/mTld and distinct from human or murine mTll-1 is presented. The gene is similar in structure to members of the BMP-1 family of genes, but maps to a distinct location and encodes a distinct protein having distinct activities. The protein encoded by the gene can be used to screen putative therapeutic agents in an ongoing effort to inhibit activity of the BMP-1 family of genes to prevent scarring, fibrosis, and the like.
    Type: Grant
    Filed: April 2, 1999
    Date of Patent: June 17, 2003
    Assignee: Wiconsin Alumni Research Foundation
    Inventors: Daniel S. Greenspan, Ian C. Scott, Christina L. Thomas
  • MAMMALIAN TOLLOID-LIKE GENE AND PROTEIN
    Publication number: 20020150946
    Abstract: A mammalian gene encoding a tolloid-like protein distinct from human or murine BMP-1/mTld and distinct from human or murine mTll-1 is presented. The gene is similar in structure to members of the BMP-1 family of genes, but maps to a distinct location and encodes a distinct protein having distinct activities. The protein encoded by the gene can be used to screen putative therapeutic agents in an ongoing effort to inhibit activity of the BMP-1 family of genes to prevent scarring, fibrosis, and the like.
    Type: Application
    Filed: April 2, 1999
    Publication date: October 17, 2002
    Inventors: DANIEL S. GREENSPAN, IAN C. SCOTT, CHRISTINA L. THOMAS